1. Home
  2. KROS vs MOFG Comparison

KROS vs MOFG Comparison

Compare KROS & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • MOFG
  • Stock Information
  • Founded
  • KROS 2015
  • MOFG 1934
  • Country
  • KROS United States
  • MOFG United States
  • Employees
  • KROS N/A
  • MOFG N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • MOFG Major Banks
  • Sector
  • KROS Health Care
  • MOFG Finance
  • Exchange
  • KROS Nasdaq
  • MOFG Nasdaq
  • Market Cap
  • KROS 558.9M
  • MOFG 582.7M
  • IPO Year
  • KROS 2020
  • MOFG N/A
  • Fundamental
  • Price
  • KROS $14.68
  • MOFG $30.37
  • Analyst Decision
  • KROS Buy
  • MOFG Buy
  • Analyst Count
  • KROS 13
  • MOFG 2
  • Target Price
  • KROS $20.63
  • MOFG $35.50
  • AVG Volume (30 Days)
  • KROS 468.5K
  • MOFG 188.7K
  • Earning Date
  • KROS 08-06-2025
  • MOFG 07-24-2025
  • Dividend Yield
  • KROS N/A
  • MOFG 3.27%
  • EPS Growth
  • KROS N/A
  • MOFG N/A
  • EPS
  • KROS 0.11
  • MOFG N/A
  • Revenue
  • KROS $214,713,000.00
  • MOFG $76,604,000.00
  • Revenue This Year
  • KROS $5,006.76
  • MOFG $239.79
  • Revenue Next Year
  • KROS N/A
  • MOFG $6.34
  • P/E Ratio
  • KROS $133.63
  • MOFG N/A
  • Revenue Growth
  • KROS 91657.70
  • MOFG N/A
  • 52 Week Low
  • KROS $9.12
  • MOFG $24.62
  • 52 Week High
  • KROS $72.37
  • MOFG $34.56
  • Technical
  • Relative Strength Index (RSI)
  • KROS 64.67
  • MOFG 53.79
  • Support Level
  • KROS $13.26
  • MOFG $29.40
  • Resistance Level
  • KROS $14.68
  • MOFG $30.50
  • Average True Range (ATR)
  • KROS 0.41
  • MOFG 0.76
  • MACD
  • KROS 0.12
  • MOFG 0.12
  • Stochastic Oscillator
  • KROS 89.35
  • MOFG 61.19

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About MOFG MidWestOne Financial Gp

MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.

Share on Social Networks: